21015 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Multivalent fibronectin based scaffold domain proteins
#902ABSORBABLE IN SITU GEL-FORMING SYSTEM, METHOD OF MAKING AND USE THEREOF
#903NUTRITIONAL BEVERAGE POWDER AND METHOD OF MAKING SAME
#904Compositions for Regenerating Defective or Absent Myocardium
#905Methods and compositions for enhancing the uptake of therapeutic agents by target cells
#906Integrin-blocking polypeptides and uses thereof
#907METHODS FOR STIMULATING HAIR GROWTH
#908Method for preparing biocompatible and biodegradable biomaterials based on collagen and granules of hydroxyapatite/β-tricalcium phosphate for use in surgery, and biomaterials thus obtained
#909Cross-linked compositions
#910Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
#911Fibronectin based scaffold domain proteins that bind to myostatin
#912Devices and methods for treating defects in the tissue of a living being
#913Treating cartilage defect with UCB-MSC expressing TSP-2
#914Cysteine Peptide-Containing Health Drink
#915Immunocompatible chorionic membrane products
#916Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
#917Immunocompatible amniotic membrane products
#918VETERINARY SUPPLEMENTS
#919Degradation-stabilised, biocompatible collagen matrices
#920Wound healing compositions
#921Bone graft materials containing calcium phosphate and chitosan
#922COLLAGEN HYDROLYSATE AND USE THEREOF
#923Cell secreted proteins for the treatment of myocardial infarction
#924Fabrication method for stratified and layered tissue to repair osteochondral defects
#925Compositions for regenerating defective or absent myocardium
#926In Vivo Synthesis of Elastic Fiber
#927Stomatological composition
#928COMPOSITE COMPOSITIONS AND APPLICATIONS THEREOF
#929PREVENTIVE AGENT FOR ATOPIC DERMATITIS
#930Regeneration of spinal discs
#931CARTILAGE CELL TREATMENT COMPRISING COLLAGEN, HYALURONIC ACID DERIVATIVE, AND STEM CELL DERIVED FROM MAMMAL UMBILICAL CORD
#932LAMININS, DERIVATIVES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE
#933Collagen matrix with locally controlled intrafibrillar and extrafibrillar mineral content and methods of producing
#934Sulphated hyaluronic acid for treating degenerative osteoarthritis
#935Methods and compositions to modify the immunogenicity of a vascularized organ or tissue
#936COMPOSITIONS AND METHODS FOR TREATING SURFACE WOUNDS
#937Corneal stiffening for treating astigmatism
#938Method of preparing bone material having enhanced osteoinductivity
#939Compositions and methods for treating organ dysfunction
#940MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS
#941THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF
#942SILK-ELASTIN LIKE PROTEIN POLYMERS FOR EMBOLIZATION AND CHEMOEMBOLIZATION TO TREAT CANCER
#943Compression-resistant collagen-based artificial bone repair material
#944METHODS FOR PREPARATION OF NEO-CARTILAGE CONSTRUCTS
#945Pluripotent therapeutic compositions and uses thereof
#946METHOD OF MODULATING NEOVASCULARIZATION
#947Inhibitors of type 2 vascular endothelial growth factor receptors
#948Devices and methods for the regeneration of bony defects
#949Methods of using myelin basic protein peptide compositions
#950EGFR and C-Met fibronectin type III domain binding molecules
#951EGFR and c-Met fibronectin type III domain binding molecules
#952ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
#953Delivery substrates from aligned polymer biomaterials for tissue repair
#954Flexible tissue matrix and methods for joint repair
#955Manufacturing and purification processes of Complex protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Antitrypsin (A1AT) or a combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#956Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
#957Water-soluble anti-inflammatory cream with natural ingredients base
#958Methods of manufacture of immunocompatible chorionic membrane products
#959Implants for “load bearing” bone substitutions having hierarchical organized architecture deriving from transformation of vegetal structures
#960BIOLOGIC REPLACEMENT FOR FIBRIN CLOT
#961Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
#962Methods of manufacture of immunocompatible amniotic membrane products
#963Methods of manufacture of therapeutic products comprising vitalized placental dispersions
#964Cartilage product
#965Compounds and methods for inducing chondrogenesis
#966Stable compositions containing thrombin and methods for preparation and use thereof
#967Production and delivery of a stable collagen
#968METHODS OF TREATING FIBROSING DISEASES BY INDUCTION OF IMMUNE TOLERANCE
#969Fibronectin based scaffold domain proteins that bind to myostatin
#970Fibronectin based scaffold domain proteins that bind to myostatin
#971System and method for collagen isolation
#972Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
#973COMPOSITION FOR THE ATTACHMENT OF IMPLANTS TO COLLAGEN OR OTHER COMPONENTS OF BIOLOGICAL TISSUE
#974Biomaterial of chymotryptically isolated fraction of fibroin in a hydrogel
#975METHODS OF USING CHIMERIC COILED-COIL MOLECULE
#976Methods of treating muscular dystrophy
#977METHOD FOR PREPARING DIETARY SUPPLEMENTS
#978Tendon Stem Cells
#979Method of treating a disease or condition characterised by aberrant epithelial cell proliferation
#980PROCOLLAGEN CARBOXY-TERMINAL PROPEPTIDES AS A TARGET AND TREATMENT FOR ANGIOGENESIS RELATED DISEASES
#981Therapeutic and diagnostic methods involving biglycan and utrophin
#982Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy
#983Therapeutic products comprising vitalized placental dispersions
#984Recombinant C7 and Methods of Use
#985Hemostatic compositions
#986Hemostatic preparation containing an extract of golden moss
#987Albumin-Fused Anti-Angiogenesis Peptides
#988Human placental collagen compositions, and methods of making and using the same
#989Basement Membrane Compositions and Applications Thereof
#990COMPOSITION FOR NUTRITION PURPOSES
#991Anti-fatigue composition
#992TOPICAL MIXTURE AND METHOD FOR DERMAL APPLICATION TO REMOVE EXCESS IRON AND OTHER HEAVY METALS FROM CELLULAR TISSUE
#993Chimeric fibronectin matrix mimetics and uses therof
#994Coagulating Collagen and Means for Preparing Same
#995Isolated extracellular matrix material including subserous fascia
#996Therapeutic or preventive agent for diabetes
#997Sebum secretion-blocking composition, and food or beverage containing same
#998Elastin digest compositions and methods utilizing same
#999Compositions and methods for the treatment of orthopedic disease or injury
#1000Method for improving skin appearance and reducing hair loss
#1001Articular Cartilage Mimetics
#1002Amniotic membrane preparations and purified compositions and anti-inflammation methods
#1003Bone delivery system having a therapeutic agent
#1004Non-natural gelatin-like proteins with enhanced functionality
#1005Methods and products for tissue repair
#1006Synthetic mechanical hemostatic composition, method of making and use thereof
#1007Compositions for regenerating defective or absent myocardium
#1008Method for the treatment of skin
#1009Microspheres useful for therapeutic vascular embolization
#1010Collagen hydrolysate for use to improve the health of human skin, hair and/or nails
#1011Biomimetic scaffold for bone regeneration
#1012Keratin compositions for treatment of bone deficiency or injury
#1013Implantable materials for bone repair
#1014Composition and Method for Healing of Skin Wounds
#1015Proteomic Antisense Molecular Shield and Targeting
#1016Methods and Agents for Enhancing Wound Healing
#1017Human placental collagen compositions, and methods of making and using the same
#1018COLLAGEN STRUCTURES AND METHOD OF FABRICATING THE SAME
#1019Sustained-release pharmaceutical composition
#1020TRANSDERMAL COMPOSITIONS AND METHODS FOR TREATING STRETCH MARKS
#1021COLLAGEN MIXTURE AND METHOD OF MAKING THE SAME
#1022EMD formulation comprising PGA
#1023CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE
#1024Fibronectin based scaffold domain proteins that bind PCSK9
#1025Conditioned cell culture medium compositions and methods of use
#1026Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#1027Purified amniotic membrane compositions and methods of use
#1028Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#1029BONE FIBERS HAVING EXTENDED LENGTH
#1030Method for treating ocular neovascularization
#1031Decellularized small particle tissue
#1032Tropoelastins and uses thereof
#1033Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use
#1034Method of Tissue-Selective Targeted Gene Transfer
#1035Compositions comprising the NC2 domain of collagen IX and methods of using same
#1036Method for promoting wound healing
#1037FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
#1038HYALURONIC ACID-COLLAGEN MATRICES FOR TISSUE ENGINEERING
#1039Retinol-modified collagen, method for producing same, and external composition for skin containing same
#1040LUBRICIN INJECTIONS TO MAINTAIN CARTILAGE HEALTH
#1041Methods and uses of TIE2 binding and/or activating agents
#1042Periodontal regeneration composition and method of using same
#1043Flowable formulations for tissue repair and regeneration
#1044HEMOSTATIC COMPOSITIONS
#1045Absorbable in situ gel-forming system, method of making and use thereof
#1046METHODS FOR REGENERATING SKELETAL MUSCLE
#1047HEMOSTATIC COMPOSITIONS
#1048METHODS OF TREATMENT WITH GLP-1 RECEPTOR AGONISTS
#1049Adiponectin production accelerating composition
#1050Cosmetic, external skin preparation, and medical instrument
#1051SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME
#1052PROCESS FOR MANUFACTURING COLLAGEN AND TRACE ELEMENTS FROM SEA WATER
#1053Methods for producing ECM-based biomaterials
#1054Human placental collagen compositions, and methods of making and using the same
#1055TOPICALLY ADMINISTERED, SKIN-PENETRATING GLYCOSAMINOGLYCAN FORMULATIONS SUITABLE FOR USE IN COSMETIC AND PHARMACEUTICAL APPLICATIONS
#1056COLLAGENOUS MATERIAL
#1057Method for treating amyloid disease
#1058Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1059Use of perlecan domain V in treating amyloidogenic disease
#1060Medical device with coating that promotes endothelial cell adherence
#1061Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate
#1062Crosslinked human or animal tissue products and their methods of manufacture and use
#1063Crosslinked human or animal tissue products and their methods of manufacture and use
#1064Crosslinked human or animal tissue products and their methods of manufacture and use
#1065SEBUM SECRETION-BLOCKING COMPOSITION, AND FOOD OR BEVERAGE CONTAINING SAME
#1066Osteocalcin as a treatment for male reproductive disorders
#1067USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN CANCER PROGNOSIS AND THERAPY
#1068Fibronectin based scaffold domain proteins that bind IL-23
#1069Multivalent fibronectin based scaffold domain proteins
#1070Fibronectin: growth factor chimeras
#1071Procoagulant peptides and their derivatives and uses therefor
#1072Cross-linked compositions
#1073Amniotic membrane preparations and purified compositions and anti-inflammation methods
#1074Crosslinked hydrogels and related method of preparation
#1075Fibrillar albumin for use in inhibiting cancer growth
#1076Hemostatic bio-material composition and method
#1077Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
#1078METHOD OF TREATING CONDITIONS ASSOCIATED WITH AIRWAY TISSUE REMODELING
#1079Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
#1080Wound treatments with crosslinked protein amorphous biomaterials
#1081Collagen and cell implant
#1082Soft tissue wrap
#1083BODY WEIGHT GAIN SUPPRESSING COMPOSITION AND FOOD PRODUCT COMPRISING THE SAME
#1084Purified amniotic membrane compositions and methods of use
#1085Decellularized and Delipidized Extracellular Matrix and Methods of Use
#1086TREATMENT OF EYE DISEASES USING ENCAPSULATED CELLS ENCODING AND SECRETING A NEUROPROTECTIVE FACTOR AND/OR AN ANTI-ANGIOGENIC FACTOR
#1087Depot stent comprising an elastin-based copolymer
#1088Albumin-Fused Anti-Angiogenesis Peptides
#1089COMPOSITION COMPRISING CELL AND BIOCOMPATIBLE POLYMER
#1090Methods for Treating Bacterial Infection
#1091Cosmetic, external skin preparation, and medical instrument
#1092PREVENTIVE AGENT FOR ATOPIC DERMATITIS
#1093Process for manufacturing biocompatible material
#1094Targeted delivery of therapeutic agents with lyophilized matrices
#1095Method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule
#1096Composition having lipolysis-promoting effect
#1097Human laminin α2 chain LG3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth
#1098BIOACTIVE CARBON-NANOTUBE AGAROSE COMPOSITES FOR NEURAL ENGINEERING
#1099Pharmaceutical compositions containing botulinum neurotoxin
#1100NATURAL PRODUCT INHIBITORS OF 3DG
#1101Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
#1102Flowable collagen-based hemostat and methods of use
#1103Compositions and Methods for Soft Tissue Augmentation
#1104Conditioned cell culture medium compositions and methods of use
#1105Human placental collagen compositions, and methods of making and using the same
#1106COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CONDITIONS ASSOCIATED WITH INFLAMATION
#1107AQUEOUS COMPOSITION COMPRISING GOLD NANOPARTICLES, SERUM ALBUMIN AND/OR COLLAGEN FOR LASER TISSUE WELDING
#1108Use of endostatin peptides for the treatment of fibrosis
#1109Nutritional Supplement
#1110Composition for the attachment of implants to collagen or other components of biological tissue
#1111USE OF HYALURONAN FOR PROMOTING ANGIOGENESIS
#1112Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#1113Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#1114Devices and methods for treating defects in the tissue of a living being
#1115LAMININS, DERIVATIVES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE
#1116Stem Cell Conditioned Medium Compositions
#1117Composition for inducing tissue regeneration by activating platelet-rich plasma (PRP)
#1118Biologic replacement for fibrin clot
#1119Inhibition of migration and induction of cell death by the type II collagen amino propeptides
#1120Injectible, biocompatible synthetic bone growth composition
#1121METHODS OF TREATMENT
#1122Human Placental Derived Extracellular Matrix and Uses Therof
#1123TREATMENT OF ERECTILE DYSFUNCTION USING PLATELET-RICH PLASMA
#1124Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
#1125Methods of stimulating liver regeneration
#1126Methods and compositions for in vitro and in vivo chondrogenesis
#1127Degradation-stabilised, biocompatible collagen matrices
#1128Bone regeneration agent comprising gelatin
#1129Sulphated hyaluronic acid for treating degenerative osteoarthritis
#1130Hemostatic preparation containing an extract of golden moss
#1131Method for detection and treatment of aneurysms
#1132Methods for treating neurological conditions and compositions and materials therefor
#1133Method for treating Th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
#1134Targeting agent to newly formed blood vessels
#1135EDIBLE COMPOSITIONS FOR PREVENTING HAIR LOSS
#1136Biomolecular coating for implants
#1137METHODS AND COMPOSITIONS USING ERGOTHIONEINE TO TREAT A VARIETY OF HEALTH RELATED FACTORS
#1138Collagen for use in the treatment of skin diseases
#1139Composition and device for treating bone and/or cartilage defects
#1140SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND ASSOCIATION WITH RESISTANCE TO IMMUNE TOLERANCE INDUCTION
#1141Scaffolds for cell transplantation
#1142Colloidal metal compositions and methods
#1143Compositions for treating degenerative joint diseases
#1144Process for making dry and stable hemostatic compositions
#1145PEPTIDE/PARTICLE DELIVERY SYSTEMS
#1146ANGIOGENESIS INDUCING AGENT COMPRISING RECOMBINANT GELATIN
#1147Polymeric material
#1148COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING
#1149Fibronectin based scaffold domain proteins that bind to PCSK9
#1150TARGETED DELIVERY OF THERAPEUTIC AGENTS WITH LYOPHILIZED MATRICES
#1151Synthetic diblock copolypeptide hydrogels for use in the central nervous system
#1152Tetra calcium phosphate based organophosphorus compositions and methods
#1153Materials and methods for the treatment of pathological neovascularization in the eye
#1154Collagen peptides as immune modulators
#1155Targets for Growth Factor Signalling and Methods of Therapy
#1156Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
#1157Devices and methods for treating defects in the tissue of a living being
#1158Coating Comprising An Elastin-Based Copolymer
#1159Therapeutic stem cell nutrient composition and uses thereof
#1160Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
#1161Devices and methods for treating defects in the tissue of a living being
#1162Pegylated fibrinogen precursor molecule
#1163Textured bone block implants
#1164Composite containing collagen and elastin as a dermal expander and tissue filler
#1165Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof
#1166Treatment of Fibrosis related disorders
#1167Injectable biomaterials
#1168VALPROIC ACID, DERIVATIVES, ANALOGUES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE
#1169TREATMENT OF LEG ULCERS USING PLACENTA DERIVED COLLAGEN BIOFABRIC
#1170Compositions and methods for suppressing fibrocytes
#1171Human placental collagen compositions and methods of making and using the same
#1172BIOLOGIC REPLACEMENT FOR FIBRIN CLOT
#1173Pullulan regenerative matrix
#1174COMPOUNDS AND METHODS FOR INHIBITING MMP2 AND MMP9
#1175Methods of generating and using procollagen
#1176Fenestrated wound repair scaffold
#1177Flowable wound matrix and its preparation and use
#1178Method of accelerating osteogenic differentiation and composition thereof
#1179IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#1180Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
#1181IMPLANTABLE MEDICAL ARTICLES HAVING LAMININ COATINGS AND METHODS OF USE
#1182Biomaterial Compositions and Methods of Use
#1183Process for producing inorganic interconnected 3D open cell bone substitutes
#1184Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1185Method of Enhancing Biological Activity of Plant Extracts
#1186SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DRIVATIVES THEREOF, UNDENATURED TYPE II COLLAGEN AND, OPTIONALLY, GLUCOSAMINE SULFATE
#1187Anti-fatigue composition
#1188Devices and methods for the regeneration of bony defects
#1189Composition and method for reducing blood glucose levels
#1190IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#1191METHODS OF MANUFACTURE OF THERAPEUTIC PRODUCTS COMPRISING VITALIZED PLACENTAL DISPERSIONS
#1192THERAPEUTIC PRODUCTS COMPRISING VITALIZED PLACENTAL DISPERSIONS
#1193METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#1194METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#1195METHODS TO IDENTIFY FACTORS ASSOCIATED WITH MUSCLE GROWTH AND USES THEREOF
#1196MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR EMBOLIZATION
#1197Modified vasoactive intestinal peptides
#1198PROTEIC ACID POLYMER, PRODUCTION PROCESSES, USE OF PROTEIC ACID POLYMER, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
#1199Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
#1200METHODS AND COMPOSITIONS FOR USE OF ANGIOGENESIS INHIBITORS IN THE PREVENTION AND/OR CONTROL OF EPILEPSY